These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 25793627)
1. Cholesterol Gallstones Larger Than 3 cm Appear to Be Associated With Gallbladder Cancer: Identification of a High Risk Group of Patients That Could Benefit From Preventive Cholecystectomy. Andrea C; Enzo A Ann Surg; 2016 Mar; 263(3):e56. PubMed ID: 25793627 [No Abstract] [Full Text] [Related]
2. Could Type and Size of Gallstones Influence Gallbladder Carcinogenesis? Jain K; Garg PK Ann Surg; 2016 Mar; 263(3):e57. PubMed ID: 25575261 [No Abstract] [Full Text] [Related]
3. Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer. Jain K; Mohapatra T; Das P; Misra MC; Gupta SD; Ghosh M; Kabra M; Bansal VK; Kumar S; Sreenivas V; Garg PK Ann Surg; 2014 Dec; 260(6):1073-80. PubMed ID: 24827397 [TBL] [Abstract][Full Text] [Related]
4. TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma. Moreno M; Pimentel F; Gazdar AF; Wistuba II; Miquel JF Ann Hepatol; 2005; 4(3):192-9. PubMed ID: 16177659 [TBL] [Abstract][Full Text] [Related]
5. Cholesterol gallstones and cancer of gallbladder (CAGB): molecular links. Venniyoor A Med Hypotheses; 2008; 70(3):646-53. PubMed ID: 17855001 [TBL] [Abstract][Full Text] [Related]
7. Dysfunction of subtelomeric methylation and telomere length in gallstone disease and gallbladder cancer patients of North Central India. Poojary SS; Mishra G; Gupta S; Shrivastav BR; Tiwari PK J Hepatobiliary Pancreat Sci; 2016 May; 23(5):276-82. PubMed ID: 26856965 [TBL] [Abstract][Full Text] [Related]
8. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma. Wistuba II; Ashfaq R; Maitra A; Alvarez H; Riquelme E; Gazdar AF Am J Pathol; 2002 Jun; 160(6):2073-9. PubMed ID: 12057912 [TBL] [Abstract][Full Text] [Related]
9. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases. da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes. Singh TD; Gupta S; Shrivastav BR; Tiwari PK Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195 [TBL] [Abstract][Full Text] [Related]
11. Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease. Sharma P; Bhunia S; Poojary SS; Tekcham DS; Barbhuiya MA; Gupta S; Shrivastav BR; Tiwari PK Tumour Biol; 2016 Nov; 37(11):14687-14699. PubMed ID: 27623942 [TBL] [Abstract][Full Text] [Related]
12. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Sheth S; Bedford A; Chopra S Am J Gastroenterol; 2000 Jun; 95(6):1402-10. PubMed ID: 10894571 [TBL] [Abstract][Full Text] [Related]
14. [Intraepithelial neoplasia of gall bladder]. Teng XD; Lai MD Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):781-4. PubMed ID: 20079024 [No Abstract] [Full Text] [Related]